➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Baxter
Moodys
Dow
McKesson

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent Applications for asenapine maleate

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US Patent Applications for asenapine maleate

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Start Trial   Start Trial Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists 2005-02-14 Abandoned -- Failure to Respond to an Office Action 2009-08-24
  Start Trial   Start Trial Therapeutic combination for cognititon enhancement and psychotic disorders 2004-12-20 Abandoned -- Failure to Respond to an Office Action 2009-01-05
  Start Trial   Start Trial Combination of atypical antipsychotics and 5HT-1B receptor antagonists 2005-05-11 Abandoned -- Failure to Respond to an Office Action 2009-08-28
  Start Trial   Start Trial Treatment of bipolar disorders and associated symptoms 2005-10-11 Abandoned -- Failure to Respond to an Office Action 2012-03-22
  Start Trial   Start Trial Asenapine for the treatment of schizophrenia in a patient with overweight or predisposition for overweight 2006-02-04 Abandoned -- Failure to Respond to an Office Action 2011-09-13
  Start Trial   Start Trial Azabenzoxazoles for the treatment of CNS disorders 2005-11-11 Abandoned -- Failure to Respond to an Office Action 2009-03-02
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
AstraZeneca
Dow
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.